yes, share price should suffer. Profitable company, in a growing industry. NTA at 21 cents. yet share trading at 3.3 cents.. isn’t that enough suffering already?? Oversold , way oversold... IMHO
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game